Structure

Physi-Chem Properties

Molecular Weight:  472.36
Volume:  514.542
LogP:  4.423
LogD:  4.132
LogS:  -4.727
# Rotatable Bonds:  2
TPSA:  77.76
# H-Bond Aceptor:  4
# H-Bond Donor:  3
# Rings:  5
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.486
Synthetic Accessibility Score:  5.284
Fsp3:  0.9
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.011
MDCK Permeability:  7.366091267613228e-06
Pgp-inhibitor:  0.833
Pgp-substrate:  0.022
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.853
30% Bioavailability (F30%):  0.948

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.754
Plasma Protein Binding (PPB):  89.50432586669922%
Volume Distribution (VD):  0.871
Pgp-substrate:  6.080494403839111%

ADMET: Metabolism

CYP1A2-inhibitor:  0.013
CYP1A2-substrate:  0.464
CYP2C19-inhibitor:  0.021
CYP2C19-substrate:  0.914
CYP2C9-inhibitor:  0.124
CYP2C9-substrate:  0.086
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.067
CYP3A4-inhibitor:  0.798
CYP3A4-substrate:  0.672

ADMET: Excretion

Clearance (CL):  8.634
Half-life (T1/2):  0.376

ADMET: Toxicity

hERG Blockers:  0.063
Human Hepatotoxicity (H-HT):  0.269
Drug-inuced Liver Injury (DILI):  0.043
AMES Toxicity:  0.01
Rat Oral Acute Toxicity:  0.832
Maximum Recommended Daily Dose:  0.724
Skin Sensitization:  0.277
Carcinogencity:  0.387
Eye Corrosion:  0.12
Eye Irritation:  0.099
Respiratory Toxicity:  0.983

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC190554

Natural Product ID:  NPC190554
Common Name*:   Rubiarbonone B
IUPAC Name:   (1R,3S,3aR,5aS,5bS,6S,7aR,11aS,13aR,13bR)-1,6-dihydroxy-3a-(hydroxymethyl)-5a,8,8,11a,13a-pentamethyl-3-propan-2-yl-2,3,4,5,5b,6,7,7a,10,11,13,13b-dodecahydro-1H-cyclopenta[a]chrysen-9-one
Synonyms:  
Standard InCHIKey:  BNCWPGHWXAEYNK-MEKJSECDSA-N
Standard InCHI:  InChI=1S/C30H48O4/c1-17(2)19-14-21(33)25-29(7)11-8-18-24(28(29,6)12-13-30(19,25)16-31)20(32)15-22-26(3,4)23(34)9-10-27(18,22)5/h8,17,19-22,24-25,31-33H,9-16H2,1-7H3/t19-,20-,21+,22-,24-,25+,27+,28-,29+,30+/m0/s1
SMILES:  CC(C)[C@@H]1C[C@H]([C@@H]2[C@@]3(C)CC=C4[C@@H]([C@H](C[C@H]5C(C)(C)C(=O)CC[C@]45C)O)[C@]3(C)CC[C@@]12CO)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL511777
PubChem CID:   44566782
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[12350148]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[12762798]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[21044847]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. root n.a. PMID[21973054]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota roots n.a. n.a. PMID[21973054]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16607 Rubia yunnanensis Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified Inhibition = -13.7 % PMID[500683]
NPT2 Others Unspecified Inhibition = -9.7 % PMID[500683]
NPT2 Others Unspecified Inhibition = 4.3 % PMID[500683]
NPT2 Others Unspecified Inhibition = 16.9 % PMID[500683]
NPT2 Others Unspecified Inhibition = 19.7 % PMID[500683]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC190554 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9783 High Similarity NPC15390
0.9278 High Similarity NPC231530
0.9278 High Similarity NPC278628
0.9239 High Similarity NPC111015
0.9158 High Similarity NPC83709
0.9091 High Similarity NPC94529
0.9043 High Similarity NPC173272
0.8936 High Similarity NPC472485
0.8936 High Similarity NPC48330
0.8901 High Similarity NPC193360
0.8889 High Similarity NPC24277
0.8878 High Similarity NPC191892
0.8854 High Similarity NPC477854
0.8842 High Similarity NPC49371
0.8842 High Similarity NPC477853
0.883 High Similarity NPC245972
0.883 High Similarity NPC196485
0.8804 High Similarity NPC186688
0.88 High Similarity NPC220229
0.88 High Similarity NPC475060
0.8763 High Similarity NPC154072
0.8763 High Similarity NPC110149
0.875 High Similarity NPC18509
0.8737 High Similarity NPC127063
0.8737 High Similarity NPC473240
0.8725 High Similarity NPC197428
0.8723 High Similarity NPC206810
0.8723 High Similarity NPC470376
0.8723 High Similarity NPC470375
0.8713 High Similarity NPC217201
0.871 High Similarity NPC100313
0.87 High Similarity NPC296945
0.87 High Similarity NPC85829
0.87 High Similarity NPC202167
0.87 High Similarity NPC260268
0.87 High Similarity NPC150531
0.87 High Similarity NPC49958
0.87 High Similarity NPC302607
0.87 High Similarity NPC149047
0.87 High Similarity NPC152695
0.87 High Similarity NPC476027
0.87 High Similarity NPC97202
0.87 High Similarity NPC214264
0.87 High Similarity NPC48733
0.87 High Similarity NPC319077
0.87 High Similarity NPC171137
0.87 High Similarity NPC50692
0.8696 High Similarity NPC53911
0.8696 High Similarity NPC328539
0.8696 High Similarity NPC328313
0.8687 High Similarity NPC140723
0.8667 High Similarity NPC209802
0.8667 High Similarity NPC124172
0.8667 High Similarity NPC82902
0.8667 High Similarity NPC221758
0.8667 High Similarity NPC59453
0.866 High Similarity NPC114274
0.8646 High Similarity NPC476318
0.8646 High Similarity NPC476327
0.8632 High Similarity NPC471207
0.8632 High Similarity NPC280804
0.8627 High Similarity NPC11710
0.8617 High Similarity NPC185936
0.8617 High Similarity NPC272746
0.8617 High Similarity NPC168027
0.8614 High Similarity NPC83744
0.8614 High Similarity NPC165873
0.8602 High Similarity NPC275740
0.8602 High Similarity NPC31985
0.8602 High Similarity NPC105495
0.8602 High Similarity NPC76879
0.8602 High Similarity NPC32830
0.8602 High Similarity NPC1015
0.8602 High Similarity NPC477943
0.8602 High Similarity NPC474245
0.8602 High Similarity NPC86319
0.86 High Similarity NPC209502
0.86 High Similarity NPC75531
0.86 High Similarity NPC29705
0.86 High Similarity NPC149124
0.86 High Similarity NPC204833
0.86 High Similarity NPC477812
0.8587 High Similarity NPC475740
0.8587 High Similarity NPC317590
0.8586 High Similarity NPC185530
0.8586 High Similarity NPC193934
0.8586 High Similarity NPC271980
0.8571 High Similarity NPC474218
0.8571 High Similarity NPC144956
0.8571 High Similarity NPC218383
0.8557 High Similarity NPC189880
0.8557 High Similarity NPC108078
0.8556 High Similarity NPC110778
0.8556 High Similarity NPC476082
0.8556 High Similarity NPC278648
0.8542 High Similarity NPC469599
0.8529 High Similarity NPC329417
0.8526 High Similarity NPC475255
0.8526 High Similarity NPC244356
0.8526 High Similarity NPC477855
0.8526 High Similarity NPC224060
0.8515 High Similarity NPC475571
0.8511 High Similarity NPC171441
0.8511 High Similarity NPC85173
0.85 High Similarity NPC26478
0.85 High Similarity NPC117185
0.8495 Intermediate Similarity NPC131470
0.8495 Intermediate Similarity NPC143767
0.8495 Intermediate Similarity NPC470542
0.8495 Intermediate Similarity NPC471722
0.8478 Intermediate Similarity NPC51014
0.8478 Intermediate Similarity NPC474732
0.8478 Intermediate Similarity NPC474778
0.8478 Intermediate Similarity NPC31564
0.8478 Intermediate Similarity NPC145879
0.8478 Intermediate Similarity NPC469994
0.8478 Intermediate Similarity NPC20688
0.8478 Intermediate Similarity NPC474733
0.8469 Intermediate Similarity NPC58942
0.8469 Intermediate Similarity NPC260149
0.8462 Intermediate Similarity NPC475798
0.8462 Intermediate Similarity NPC127606
0.8454 Intermediate Similarity NPC5532
0.8454 Intermediate Similarity NPC304899
0.8454 Intermediate Similarity NPC253115
0.8454 Intermediate Similarity NPC469545
0.8454 Intermediate Similarity NPC61369
0.8444 Intermediate Similarity NPC151519
0.8444 Intermediate Similarity NPC470614
0.8444 Intermediate Similarity NPC1272
0.8438 Intermediate Similarity NPC209662
0.8438 Intermediate Similarity NPC191094
0.8438 Intermediate Similarity NPC166906
0.8438 Intermediate Similarity NPC302008
0.8431 Intermediate Similarity NPC144459
0.8431 Intermediate Similarity NPC477916
0.8421 Intermediate Similarity NPC23434
0.8421 Intermediate Similarity NPC476168
0.8421 Intermediate Similarity NPC154101
0.8416 Intermediate Similarity NPC137657
0.8404 Intermediate Similarity NPC474704
0.8404 Intermediate Similarity NPC69627
0.8404 Intermediate Similarity NPC475921
0.84 Intermediate Similarity NPC473424
0.84 Intermediate Similarity NPC22388
0.84 Intermediate Similarity NPC477915
0.8387 Intermediate Similarity NPC58063
0.8387 Intermediate Similarity NPC472495
0.8387 Intermediate Similarity NPC73064
0.8387 Intermediate Similarity NPC153604
0.8387 Intermediate Similarity NPC57469
0.8387 Intermediate Similarity NPC474684
0.8387 Intermediate Similarity NPC298904
0.8387 Intermediate Similarity NPC142361
0.8387 Intermediate Similarity NPC4643
0.8381 Intermediate Similarity NPC71348
0.837 Intermediate Similarity NPC470574
0.837 Intermediate Similarity NPC133954
0.837 Intermediate Similarity NPC197823
0.837 Intermediate Similarity NPC202868
0.837 Intermediate Similarity NPC469948
0.8367 Intermediate Similarity NPC170978
0.8352 Intermediate Similarity NPC477818
0.8352 Intermediate Similarity NPC475726
0.8352 Intermediate Similarity NPC193870
0.8352 Intermediate Similarity NPC141941
0.8352 Intermediate Similarity NPC472743
0.8351 Intermediate Similarity NPC45324
0.8351 Intermediate Similarity NPC138245
0.8351 Intermediate Similarity NPC279974
0.8351 Intermediate Similarity NPC222845
0.8351 Intermediate Similarity NPC231060
0.8351 Intermediate Similarity NPC271195
0.8351 Intermediate Similarity NPC139570
0.8351 Intermediate Similarity NPC473170
0.8351 Intermediate Similarity NPC317586
0.8351 Intermediate Similarity NPC470016
0.8351 Intermediate Similarity NPC472932
0.8351 Intermediate Similarity NPC84018
0.8351 Intermediate Similarity NPC162001
0.8351 Intermediate Similarity NPC200702
0.835 Intermediate Similarity NPC65941
0.8333 Intermediate Similarity NPC12722
0.8333 Intermediate Similarity NPC257353
0.8333 Intermediate Similarity NPC181594
0.8333 Intermediate Similarity NPC144739
0.8333 Intermediate Similarity NPC69454
0.8333 Intermediate Similarity NPC60681
0.8317 Intermediate Similarity NPC312900
0.8317 Intermediate Similarity NPC55872
0.8316 Intermediate Similarity NPC183283
0.8316 Intermediate Similarity NPC136801
0.8316 Intermediate Similarity NPC48010
0.8316 Intermediate Similarity NPC126993
0.8316 Intermediate Similarity NPC320026
0.8316 Intermediate Similarity NPC80401
0.8302 Intermediate Similarity NPC108721
0.8302 Intermediate Similarity NPC73300
0.8302 Intermediate Similarity NPC202889
0.83 Intermediate Similarity NPC474327

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC190554 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8804 High Similarity NPD5328 Approved
0.875 High Similarity NPD4755 Approved
0.8667 High Similarity NPD4786 Approved
0.8617 High Similarity NPD6079 Approved
0.8571 High Similarity NPD4696 Approved
0.8571 High Similarity NPD5286 Approved
0.8571 High Similarity NPD5285 Approved
0.8571 High Similarity NPD4700 Approved
0.8526 High Similarity NPD4202 Approved
0.8485 Intermediate Similarity NPD5223 Approved
0.8444 Intermediate Similarity NPD3667 Approved
0.84 Intermediate Similarity NPD4633 Approved
0.84 Intermediate Similarity NPD5225 Approved
0.84 Intermediate Similarity NPD5224 Approved
0.84 Intermediate Similarity NPD5226 Approved
0.84 Intermediate Similarity NPD5211 Phase 2
0.8333 Intermediate Similarity NPD6402 Approved
0.8333 Intermediate Similarity NPD7128 Approved
0.8333 Intermediate Similarity NPD6675 Approved
0.8333 Intermediate Similarity NPD5739 Approved
0.8317 Intermediate Similarity NPD5175 Approved
0.8317 Intermediate Similarity NPD4754 Approved
0.8317 Intermediate Similarity NPD5174 Approved
0.828 Intermediate Similarity NPD3618 Phase 1
0.8265 Intermediate Similarity NPD5221 Approved
0.8265 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.8265 Intermediate Similarity NPD5222 Approved
0.8265 Intermediate Similarity NPD4697 Phase 3
0.8261 Intermediate Similarity NPD3133 Approved
0.8261 Intermediate Similarity NPD3665 Phase 1
0.8261 Intermediate Similarity NPD3666 Approved
0.8235 Intermediate Similarity NPD5141 Approved
0.819 Intermediate Similarity NPD4634 Approved
0.8182 Intermediate Similarity NPD5173 Approved
0.8173 Intermediate Similarity NPD6899 Approved
0.8173 Intermediate Similarity NPD6881 Approved
0.8173 Intermediate Similarity NPD7320 Approved
0.8155 Intermediate Similarity NPD4768 Approved
0.8155 Intermediate Similarity NPD4767 Approved
0.8144 Intermediate Similarity NPD6399 Phase 3
0.8095 Intermediate Similarity NPD6372 Approved
0.8095 Intermediate Similarity NPD6373 Approved
0.8077 Intermediate Similarity NPD5701 Approved
0.8077 Intermediate Similarity NPD5697 Approved
0.8041 Intermediate Similarity NPD7515 Phase 2
0.8022 Intermediate Similarity NPD7525 Registered
0.8021 Intermediate Similarity NPD4753 Phase 2
0.8019 Intermediate Similarity NPD7290 Approved
0.8019 Intermediate Similarity NPD6883 Approved
0.8019 Intermediate Similarity NPD7102 Approved
0.8 Intermediate Similarity NPD5128 Approved
0.8 Intermediate Similarity NPD6011 Approved
0.8 Intermediate Similarity NPD4729 Approved
0.8 Intermediate Similarity NPD4730 Approved
0.7981 Intermediate Similarity NPD6008 Approved
0.7979 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7963 Intermediate Similarity NPD4632 Approved
0.7944 Intermediate Similarity NPD6869 Approved
0.7944 Intermediate Similarity NPD6649 Approved
0.7944 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7944 Intermediate Similarity NPD6847 Approved
0.7944 Intermediate Similarity NPD6650 Approved
0.7944 Intermediate Similarity NPD6617 Approved
0.7944 Intermediate Similarity NPD8130 Phase 1
0.7925 Intermediate Similarity NPD6013 Approved
0.7925 Intermediate Similarity NPD6014 Approved
0.7925 Intermediate Similarity NPD6012 Approved
0.7872 Intermediate Similarity NPD3668 Phase 3
0.787 Intermediate Similarity NPD6882 Approved
0.787 Intermediate Similarity NPD8297 Approved
0.785 Intermediate Similarity NPD5249 Phase 3
0.785 Intermediate Similarity NPD5247 Approved
0.785 Intermediate Similarity NPD5248 Approved
0.785 Intermediate Similarity NPD5250 Approved
0.785 Intermediate Similarity NPD5135 Approved
0.785 Intermediate Similarity NPD5169 Approved
0.785 Intermediate Similarity NPD5251 Approved
0.785 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD4221 Approved
0.7849 Intermediate Similarity NPD4223 Phase 3
0.7789 Intermediate Similarity NPD5329 Approved
0.7778 Intermediate Similarity NPD5127 Approved
0.7778 Intermediate Similarity NPD5215 Approved
0.7778 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD5217 Approved
0.7778 Intermediate Similarity NPD5216 Approved
0.7766 Intermediate Similarity NPD4788 Approved
0.7748 Intermediate Similarity NPD6009 Approved
0.7745 Intermediate Similarity NPD7638 Approved
0.7736 Intermediate Similarity NPD6412 Phase 2
0.7732 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.77 Intermediate Similarity NPD7748 Approved
0.7699 Intermediate Similarity NPD6059 Approved
0.7699 Intermediate Similarity NPD6054 Approved
0.7684 Intermediate Similarity NPD4197 Approved
0.7677 Intermediate Similarity NPD8035 Phase 2
0.7677 Intermediate Similarity NPD8034 Phase 2
0.767 Intermediate Similarity NPD7640 Approved
0.767 Intermediate Similarity NPD7639 Approved
0.7667 Intermediate Similarity NPD6942 Approved
0.7667 Intermediate Similarity NPD7339 Approved
0.7667 Intermediate Similarity NPD3703 Phase 2
0.7647 Intermediate Similarity NPD7902 Approved
0.7647 Intermediate Similarity NPD6083 Phase 2
0.7647 Intermediate Similarity NPD6084 Phase 2
0.7624 Intermediate Similarity NPD4629 Approved
0.7624 Intermediate Similarity NPD5210 Approved
0.7568 Intermediate Similarity NPD5167 Approved
0.7565 Intermediate Similarity NPD6370 Approved
0.7544 Intermediate Similarity NPD6319 Approved
0.7542 Intermediate Similarity NPD7736 Approved
0.7526 Intermediate Similarity NPD6684 Approved
0.7526 Intermediate Similarity NPD7334 Approved
0.7526 Intermediate Similarity NPD5330 Approved
0.7526 Intermediate Similarity NPD7521 Approved
0.7526 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7526 Intermediate Similarity NPD5205 Approved
0.7526 Intermediate Similarity NPD4689 Approved
0.7526 Intermediate Similarity NPD6409 Approved
0.7526 Intermediate Similarity NPD7146 Approved
0.7526 Intermediate Similarity NPD4690 Approved
0.7526 Intermediate Similarity NPD4688 Approved
0.7526 Intermediate Similarity NPD4693 Phase 3
0.7526 Intermediate Similarity NPD4138 Approved
0.7526 Intermediate Similarity NPD5279 Phase 3
0.7522 Intermediate Similarity NPD6335 Approved
0.75 Intermediate Similarity NPD5168 Approved
0.75 Intermediate Similarity NPD6274 Approved
0.75 Intermediate Similarity NPD7604 Phase 2
0.7478 Intermediate Similarity NPD6016 Approved
0.7478 Intermediate Similarity NPD6015 Approved
0.7478 Intermediate Similarity NPD5983 Phase 2
0.7456 Intermediate Similarity NPD7101 Approved
0.7456 Intermediate Similarity NPD7100 Approved
0.7449 Intermediate Similarity NPD4751 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD7492 Approved
0.7434 Intermediate Similarity NPD6317 Approved
0.7419 Intermediate Similarity NPD6114 Approved
0.7419 Intermediate Similarity NPD6697 Approved
0.7419 Intermediate Similarity NPD6115 Approved
0.7419 Intermediate Similarity NPD6118 Approved
0.7414 Intermediate Similarity NPD5988 Approved
0.7374 Intermediate Similarity NPD6903 Approved
0.7373 Intermediate Similarity NPD6336 Discontinued
0.7373 Intermediate Similarity NPD6616 Approved
0.7373 Intermediate Similarity NPD7507 Approved
0.7368 Intermediate Similarity NPD6313 Approved
0.7368 Intermediate Similarity NPD6314 Approved
0.7353 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD7900 Approved
0.7347 Intermediate Similarity NPD5280 Approved
0.7347 Intermediate Similarity NPD5690 Phase 2
0.7347 Intermediate Similarity NPD4694 Approved
0.734 Intermediate Similarity NPD7645 Phase 2
0.7333 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7328 Intermediate Similarity NPD6908 Approved
0.7328 Intermediate Similarity NPD6909 Approved
0.7327 Intermediate Similarity NPD5281 Approved
0.7327 Intermediate Similarity NPD5284 Approved
0.7312 Intermediate Similarity NPD6116 Phase 1
0.7311 Intermediate Similarity NPD7078 Approved
0.7311 Intermediate Similarity NPD8293 Discontinued
0.7282 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD5695 Phase 3
0.725 Intermediate Similarity NPD6033 Approved
0.7238 Intermediate Similarity NPD5696 Approved
0.7222 Intermediate Similarity NPD4244 Approved
0.7222 Intermediate Similarity NPD4245 Approved
0.7204 Intermediate Similarity NPD6117 Approved
0.72 Intermediate Similarity NPD6672 Approved
0.72 Intermediate Similarity NPD5737 Approved
0.7193 Intermediate Similarity NPD6868 Approved
0.719 Intermediate Similarity NPD7319 Approved
0.7188 Intermediate Similarity NPD4692 Approved
0.7188 Intermediate Similarity NPD4139 Approved
0.7179 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.7174 Intermediate Similarity NPD4785 Approved
0.7174 Intermediate Similarity NPD4784 Approved
0.7172 Intermediate Similarity NPD6098 Approved
0.7158 Intermediate Similarity NPD4195 Approved
0.7143 Intermediate Similarity NPD4243 Approved
0.713 Intermediate Similarity NPD7115 Discovery
0.7129 Intermediate Similarity NPD6904 Approved
0.7129 Intermediate Similarity NPD6673 Approved
0.7129 Intermediate Similarity NPD6080 Approved
0.7111 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD3698 Phase 2
0.7083 Intermediate Similarity NPD4748 Discontinued
0.7083 Intermediate Similarity NPD5368 Approved
0.7083 Intermediate Similarity NPD4695 Discontinued
0.708 Intermediate Similarity NPD6053 Discontinued
0.7059 Intermediate Similarity NPD6067 Discontinued
0.7053 Intermediate Similarity NPD3617 Approved
0.7037 Intermediate Similarity NPD7632 Discontinued
0.699 Remote Similarity NPD6411 Approved
0.6989 Remote Similarity NPD6924 Approved
0.6989 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6989 Remote Similarity NPD6926 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data